A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study

MLA

Mutsumi Nishida, et al. “A Novel Strategy for SARS-CoV-2 Mass Screening with Quantitative Antigen Testing of Saliva: A Diagnostic Accuracy Study.” The Lancet. Microbe, May 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e9bd06413d6a011982f157cc142127bd&authtype=sso&custid=ns315887.

APA

Mutsumi Nishida, Kazufumi Okada, Isao Yokota, Sumio Iwasaki, Takanori Teshima, Shinichi Fujisawa, Yichi Yang, Yoko Unoki, & Peter Y Shane. (2021). A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study. The Lancet. Microbe.

Chicago

Mutsumi Nishida, Kazufumi Okada, Isao Yokota, Sumio Iwasaki, Takanori Teshima, Shinichi Fujisawa, Yichi Yang, Yoko Unoki, and Peter Y Shane. 2021. “A Novel Strategy for SARS-CoV-2 Mass Screening with Quantitative Antigen Testing of Saliva: A Diagnostic Accuracy Study.” The Lancet. Microbe, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e9bd06413d6a011982f157cc142127bd&authtype=sso&custid=ns315887.